Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
JAMP-SOLIFENACIN JAMP PHARMA CORPORATION Actual shortage 10MG Updated Report 2023-09-26 180292
JAMP-SOLIFENACIN JAMP PHARMA CORPORATION Actual shortage 5MG Updated Report 2023-09-26 180265
JAMP-SOLIFENACIN JAMP PHARMA CORPORATION Actual shortage 5MG Updated Report 2023-09-26 180262
JAMP-SOLIFENACIN JAMP PHARMA CORPORATION Actual shortage 10MG Updated Report 2023-09-26 162505
XARELTO BAYER INC Anticipated shortage 51.7MG Updated Report 2023-09-26 196859
ODAN-INDOMETHACIN ODAN LABORATORIES LTD Actual shortage 100MG New Report 2023-09-26 205248
UROMITEXAN BAXTER CORPORATION Actual shortage 100MG Updated Report 2023-09-26 203947
DICETEL BGP PHARMA ULC Anticipated shortage 100MG Updated Report 2023-09-26 198997
LIPIDIL EZ BGP PHARMA ULC Actual shortage 48MG Updated Report 2023-09-26 196707
NITROSTAT BGP PHARMA ULC Actual shortage 0.3MG Updated Report 2023-09-26 201387

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SOLIFENACIN SANIS HEALTH INC Discontinued 5MG Updated Report 2023-09-26 205215
STRATTERA ELI LILLY CANADA INC Discontinued 25MG Updated Report 2023-09-25 171485
TARO-WARFARIN TARO PHARMACEUTICALS INC Discontinued 5MG New Report 2023-09-25 205189
PMS-CIPROFLOXACIN PHARMASCIENCE INC Discontinued 250MG New Report 2023-09-20 204854
PMS-CIPROFLOXACIN PHARMASCIENCE INC Discontinued 750MG New Report 2023-09-20 204849